Hepatic microfluidic bioreactor
| Knowledge Source Identification | |
|---|---|
| Knowledge source name | Hepatic microfluidic bioreactor |
| Abbreviated name | HeMiBio |
| Owner/Developer | European Commission and Cosmetics Europe |
| Country | Belgium |
| Languages | English |
| URL | http://www.hemibio.eu/ |
| Contact | http://www.hemibio.eu/contact-us |
| Description | The goal of HeMiBio is to develop a hepatic microfluidic bioreactor from human iPSC-derived hepatocytes, hepatic sinusoidal endothelial cells (HSEC) and stellate cells (HSC), suitable for inclusion in a repeated dose toxicity testing strategy of pharmaceuticals/cosmetic ingredients. |
| Knowledge Source Category | |
| Category | Research Program/Project/Grant |
| Sub categories | EU Program |
| Knowledge Dissemination and Sharing | |
| Dissemination channel | Face-to-face, Website, Printed |
| Targeted audience (specified/objective analysis) | Scientists, Regulators, Industry, Researchers |
| Users access | Open access |
| Knowledge Characterization | |
| 3Rs relevance | Replacement |
| Purpose | Regulatory testing, Fundamental studies, Toxicological and safety evaluation, Method development |
| Technology/Tools | Stem cells, Tissue engineering, Alternative test methods (in vitro) |